What are the Gaudium IVF IPO dates?

The Gaudium IVF IPO is expected to open in Feb 2026, subject to SEBI approval. Final dates will be updated once announced officially.

What is the price band of Gaudium IVF IPO?

The price band for Gaudium IVF IPO is ₹75.00 - ₹79.00 per share.

What is the GMP today for Gaudium IVF IPO?

As per market sources, Gaudium IVF IPO GMP is currently ₹-4.00. GMP is tracked daily in the grey market. GMP indicates unofficial demand but does not guarantee listing gains.

How much subscription has happened for Gaudium IVF IPO?

The subscription status for Gaudium IVF IPO stands at 7.27x overall.

When is the Gaudium IVF IPO listing date?

The listing date for Gaudium IVF IPO is 27 Feb 2026.

Gaudium IVF IPO Listing Price, Performance & Details

Gaudium IVF IPO Important Dates
Event	Date
IPO Open Date	20 Feb 2026
IPO Close Date	24 Feb 2026
Basis of Allotment	25 Feb 2026
Initiation of Refunds	26 Feb 2026
Credit of Shares to Demat	26 Feb 2026
Listing Date	27 Feb 2026

Listing Performance

As of 27 Feb 2026

Listing day gain

+5.06%

Listed at ₹83 (issue ₹79)

Issue

₹79

Listing

₹83

Current

₹80.26

+1.59% vs issue

Day range

₹79.5 – ₹87.15

Gaudium IVF IPO Price Band & Investment Details

Issue Size

20,886,200 shares
(aggregating up to ₹165.00 Cr)

Issue Price

₹75 – ₹79

Face Value

₹5/share

Market Lot

189 shares

Retail Min Investment

₹14,931

Listing At

NSE,BSE

Sale Type

both

Fresh Issue

11,392,500 shares
(aggregating up to ₹90 Cr)

Offer for Sale

9,493,700 shares
(aggregating up to ₹75 Cr)

Issue Type

book building

Gaudium IVF IPO Timeline

Open Date

20 Feb

Close Date

24 Feb

Allotment

25 Feb

Listing

27 Feb

Gaudium IVF IPO Live GMP

Last updated: 7 months ago

Current GMP

₹-4

Previous GMP

₹-4

Gaudium IVF IPO GMP History

Date	IPO Issue Price (₹)	GMP (₹)	Est. Listing Price (₹)	Est. Profit Amount (₹)	Est. Profit %	Last Updated
26 Feb 2026 Latest	₹79	₹-4	₹75	₹-4	-5.06%	1:43 PM
25 Feb 2026	₹79	₹-4	₹75	₹-4	-5.06%	4:43 PM

Showing the 2 most recent GMP entries.

View full GMP history

Gaudium IVF IPO Subscription Status

Latest snapshot: 24 Feb 2026

Category	Subscribed (x)
QIB	1.62x
NII	14.05x
bNII (bids above ₹10L)	12.71x
sNII (bids below ₹10L)	16.73x
Retail Investors	7.6x
Total	7.27x

Showing the latest subscription snapshot.

View full subscription history

Gaudium IVF IPO Investment Limits

New to lot sizes and investment limits? Read our guide on IPO lot size and minimum investment.

Category	Lots	Shares	Amount (₹)
Retail (Min)	1	189	₹14,931
Retail (Max)	13	2,457	₹194,103
S-HNI (Min)	14	2,646	₹209,034
S-HNI (Max)	66	12,474	₹985,446
B-HNI (Min)	67	12,663	₹1,000,377

Gaudium IVF IPO Reservation Structure

Want to understand how IPO shares are divided between investor categories? Read our guide on IPO reservation structure.

Category	Shares Offered
QIB Shares Offered	10,443,100 (50.00%)
• Anchor Investor Shares Offered	6,265,860 (30.00%)
• QIB (Ex. Anchor) Shares Offered	4,177,240 (20.00%)
NII (HNI) Shares Offered	3,132,930 (15.00%)
• bNII > ₹10L	2,088,620 (10.00%)
• sNII < ₹10L	1,044,310 (5.00%)
Retail Shares Offered	7,310,170 (35.00%)
Total Shares Offered	20,886,200 (100.00%)

About Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited is a leading Indian healthcare provider specializing in advanced fertility treatments and women's health. Operating on a "Hub and Spoke" model, the company provides comprehensive IVF services including ICSI, egg freezing, and laparoscopy across 30+ locations in India. They aim to deliver "Motherhood Dreams" through high-quality clinical care and ethical medical practices.

Strengths:

Clinical Excellence: The company utilizes advanced medical technologies like Laminar Flow Hoods and Cryo Storage to ensure high success rates in IVF procedures.
Expert Leadership: Led by Dr. Manika Khanna, a pioneer in the field, the company benefits from a team of highly qualified doctors and embryologists.
Scalable Model: Their established "Hub and Spoke" infrastructure allows them to manage multiple centers efficiently while maintaining standardized care.
Robust Financials: The company has shown consistent profitability and a high Return on Net Worth (41.31% in FY25), indicating strong financial health.

Growth Strategy:

Geographic Expansion: A significant portion of IPO proceeds is dedicated to establishing new IVF centers in Tier-2 and Tier-3 cities where specialized fertility care is currently limited.
Service Diversification: Beyond IVF, the company is expanding into broader women’s health areas, including hormonal therapies and minimally invasive surgeries (laparoscopy).
Digital Reach: Increasing investments in digital marketing and awareness programs to educate Indian couples about fertility treatments and improve patient acquisition.

Gaudium IVF and Women Health Limited – Company Details, Address & Contact

Founded In: 2015
Managing Director: Dr. Manika Khanna
Website: www.gaudiumivfcentre.com
Industry: Healthcare

Addresses

Registered Office B1/51, Janak Puri, B-1, New Delhi-110058, India.

Particulars	FY 2023	FY 2024	FY 2025
Total Revenue	44.26	48.15	70.96
Profit After Tax (PAT)	13.53	10.32	19.13
EBITDA	20.07	19.27	28.63
Total Assets	36.63	51.01	88.51
Net Worth	22.73	26.99	46.3
Reserves & Surplus	21.74	26	15.6
Total Borrowing	9.78	15.73	18.93